恒瑞医药（600276.SH）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

私营企业42.92%
公众及其他29.65%
机构投资者26.57%
员工持股计划0.74%
个人与内部人士0.12%

主要股东

主要股东最新
股东
Jiangsu Hengrui Medicine Group Co., Ltd.	23.24%	15.38 亿	0.02%	+0	2026/03/31
Jiangsu Hengrui Medicine Group Co., Ltd.	23.24%	15.38 亿	<0.01%	+0	2026/03/31
Tibet Dagze Huixin Investment Management Partnership (Limited Partnership)	14.39%	9.53 亿	0.01%	+0	2026/03/31
Tibet Dagze Huixin Investment Management Partnership (Limited Partnership)	14.39%	9.53 亿	<0.01%	+0	2026/03/31
Hong Kong Exchanges and Clearing Limited	6.60%	4.37 亿	0.75%	-5,031.33 万	2026/03/31
Hong Kong Exchanges and Clearing Limited	6.60%	4.37 亿	<0.01%	+0	2026/03/31
China National Pharmaceutical Group Corporation	2.77%	1.83 亿	<0.01%	-25.00 万	2026/03/31
China National Pharmaceutical Group Corporation	2.77%	1.83 亿	<0.01%	+0	2026/03/31
Qingdao Bosentai Investment Partnership Enterprise (Limited Partnership)	2.41%	1.60 亿	<0.01%	+0	2026/03/31
Qingdao Bosentai Investment Partnership Enterprise (Limited Partnership)	2.41%	1.60 亿	<0.01%	+0	2026/03/31
Lianyungang Financial Holding Group Co., Ltd.	1.71%	1.13 亿	0.04%	+256.03 万	2026/03/31
Lianyungang Financial Holding Group Co., Ltd.	1.71%	1.13 亿	<0.01%	+0	2026/03/31
China Universal Asset Management Company Ltd.	1.29%	8,530.49 万	<0.01%	-1.67 万	2026/03/31
China Asset Management Co. Ltd.	1.25%	8,263.37 万	<0.01%	+0	2025/12/31
China Asset Management Co. Ltd.	1.25%	8,263.37 万	<0.01%	+0	2025/12/31
China Universal Asset Management Company Ltd.	1.20%	7,913.74 万	<0.01%	+0	2026/03/31
Huatai-PineBridge Fund Management Co., Ltd.	1.12%	7,436.23 万	<0.01%	+0	2025/12/31
Huatai-PineBridge Fund Management Co., Ltd.	1.12%	7,436.23 万	<0.01%	+0	2025/12/31
E Fund Management Co., Ltd.	0.95%	6,288.89 万	<0.01%	+3,057.00	2026/07/31
E Fund Management Co., Ltd.	0.95%	6,288.89 万	<0.01%	+147.00	2026/07/31